Drug Discovery News
-
Celgene halts phase III trial of cancer drug Revlimid
Drug Discovery | Regulatory | By BioSpectrum Bureau | 2 Comment | 19 Jul, 2013
Singapore: Celgene has discontinued treatment with Revlimid (lenalidomide), prescribed for for multiple myeloma, in open...Read more
-
BMS seeks Hep C therapy approval in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Nov, 2013
Singapore: Bristol-Myers Squibb has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Devices...Read more
-
Daiichi US appoints Glenn Gormley as chairman
Drug Discovery | Influencers | By BioSpectrum Bureau | 2 Comment | 04 Oct, 2013
Singapore: Daiichi Sankyo has appointed Dr Glenn Gormley, as president and chairman of Daiichi Sankyo, US. Dr Gormley w...Read more
-
Singapore nod for BMS, Pfizer heart drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 25 Nov, 2013
Singapore: Health Sciences Authority (HSA) in Singapore has approved new treatment, apixaban (Eliquis), marketed by phar...Read more
-
Aus firm to raise $10 mn for multiple sclerosis drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 Nov, 2013
Singapore: Australia medical biotechnology company, Innate Immunotherapeutics, plans to raise up to $10.93 million (A$12...Read more
-
WuXi PharmaTech partners with Pharmacyclics
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Nov, 2013
Singapore: Shanghai SynTheAll (STA) Pharmaceutical, subsidiary of WuXi PharmaTech, a leading pharmaceutical, biotechnolo...Read more
-
BHR expands brain injury treatment trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 13 Jun, 2012
Singapore: BHR Pharma has started recruiting patients, who are suffering from severe traumatic brain injury (TBI), for t...Read more
-
Astellas, Ambit Biosciences begin quizartinib trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Jun, 2012
Singapore: Japan-headquartered Astellas Pharma and Ambit Biosciences have initiated the phase IIb open-label clinical tr...Read more
-
Drug Discovery | Influencers | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
Sample preparation is a daily function in any life science research or drug discovery lab and pipetting is a fundamental...Read more
-
Bayer stops haemophilia trial amidst drug safety concern
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 May, 2013
Singapore: Bayer HealthCare has stopped its phase II/III study testing its experimental treatment BAY 86-6150 on certain...Read more
-
Boehringer seeks EU marketing nod for cancer drug
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 18 Oct, 2013
Singapore: Boehringer Ingelheim has submitted a marketing authorization application to the European Medicines Agency (EM...Read more
-
SFJ Pharma, Pfizer collaborate for dacomitinib trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Sep, 2012
Singapore: SFJ Pharmaceuticals, primarily focused on funding and executing phase III studies of drugs, has entered into ...Read more
-
BMS stops Hepatitis C inhibitor development
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Aug, 2012
Singapore: Bristol-Myers Squibb has discontinued the development of BMS-986094 (formerly known as INX-189), a nucleotide...Read more
-
FDA approves Bayer thromboembolic BP drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2013
Singapore: Bayer HealthCare has recieved US FDA approval for Adempas (riociguat) tablets for the treatment of adults wit...Read more
-
FDA red signal for Genzyme, Bayer multiple sclerosis drug
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 03 Sep, 2012
Singapore: Genzyme, a Sanofi company, received a Refuse to File letter from the US FDA in response to the supplemental B...Read more
-
NIH funds $45 mn Alzheimer's drug development
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Sep, 2013
Singapore: The National Institutes of Health (NIH) is funding $45 million for research aimed at preventing Alzheimer's ...Read more
-
Singapore firm to launch next-gen cancer study device
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 May, 2014
Singapore: Singapore's emerging company Clearbridge BioMedics plans to launch its ClearCell FX System at American Societ...Read more
-
CSL files biologics license plea with FDA
Drug Discovery | Regulatory | By BioSpectrum Bureau | 2 Comment | 30 May, 2012
Singapore: The US Food and Drug Administration (FDA) has accepted Australia-based CSL Behring's biologics license applic...Read more
